Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sarcoma Metastatic”

829 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 829 results

Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Not applicableStudy completedNCT00954473
What this trial is testing

Study of Blood Samples From Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma
Children's Oncology Group 1,000
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Ended earlyNCT01986829
What this trial is testing

Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy

Who this might be right for
OsteosarcomaSarcoma
Washington University School of Medicine 9
Testing effectiveness (Phase 2)Study completedNCT00062283
What this trial is testing

Alanosine in Treating Patients With Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaPancreatic Cancer+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01514188
What this trial is testing

Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma

Who this might be right for
Metastatic Soft Tissue SarcomaLocally Advanced Soft Tissue SarcomaUnresectable Soft Tissue Sarcoma
ImmunityBio, Inc. 126
Testing effectiveness (Phase 2)Study completedNCT00003270
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT05726383
What this trial is testing

Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma

Who this might be right for
Osteogenic Sarcoma Recurrent
Hackensack Meridian Health 32
Testing effectiveness (Phase 2)Study completedNCT00413192
What this trial is testing

E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eisai Inc. 128
Early research (Phase 1)Study completedNCT01477021
What this trial is testing

Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult LiposarcomaAdult Synovial SarcomaRecurrent Adult Soft Tissue Sarcoma+2 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Early research (Phase 1)Active Not RecruitingNCT01953900
What this trial is testing

IC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma

Who this might be right for
OsteosarcomaNeuroblastoma
Baylor College of Medicine 26
Testing effectiveness (Phase 2)UnknownNCT03420014
What this trial is testing

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

Who this might be right for
Leiomyosarcoma
Philogen S.p.A. 114
Testing effectiveness (Phase 2)Active Not RecruitingNCT04784247
What this trial is testing

Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Sarcoma
Memorial Sloan Kettering Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT01391962
What this trial is testing

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 34
Post-approval studies (Phase 4)UnknownNCT00339118
What this trial is testing

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Who this might be right for
Rhabdomyosarcoma
Sheba Medical Center
Testing effectiveness (Phase 2)Study completedNCT00652860
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery

Who this might be right for
Metastatic CancerSarcoma
Mayo Clinic 39
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Early research (Phase 1)WithdrawnNCT02210104
What this trial is testing

Adoptive Therapy Using Antigen-Specific CD4 T-Cells

Who this might be right for
MelanomaSarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03660826
What this trial is testing

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Who this might be right for
Endometrial AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more
National Cancer Institute (NCI)
Load More Results
288